“FAAH Inhibitor Improves Function of Inflamed Bladders by Modulation of Anandamide and Palmitoylethanolamide” (2017) Acta Urológica Portuguesa, 34(3-4), pp. 21–28. doi:10.24915/aup.34.3-4.14.